Amgen Says Enbrel Protected By Legit Patents, Rulings

By Bryan Koenig · January 9, 2025, 8:44 PM EST

Amgen has asked a Virginia federal judge to permanently toss the latest version of a proposed class action accusing it of illegally entrenching and expanding patent rights to stave off cheaper...

To view the full article, register now.

Documents

Case Information

Case Title

Carefirst of Maryland, Inc. et al v. Amgen, Inc. et al

Case Number

2:24-cv-00484

Court

Virginia Eastern

Nature of Suit

Anti-Trust

Date Filed

August 06, 2024